Search

everythinglearnresearchcommunity

for

Search:↓

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Topical treatments led to hair regrowth in a man with linear morphea.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Technological advancements and standardization are crucial for improving diagnostic accuracy and laboratory efficiency.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

More research is needed to understand alopecia areata severity.

FOXN1 gene variants cause low T cells and immune issues from birth.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Blocking interferon-gamma might help treat various autoimmune diseases.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.